Latest filing published 06 May 2022 for Wave Life Sciences Ltd..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Michael A. Panzara: trading record in brief
Michael A. Panzara discloses dealings in Wave Life Sciences Ltd. to SEC (Form 4). In total, 18 filings cover trades dated from 11 July 2016 to 5 May 2022.
The open-market record consists of 11 sales worth €1.4M, with no purchase. Besides market trades, the filings include 6 share grants and 1 option exercise. So far in 2022, the count stands at no purchases and 2 sales.
On 6 May 2022 came the latest disclosure, an open-market sale for €27k in Wave Life Sciences Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael A. Panzara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Ordinary SharesSEC:0000899243-22-017130:0
- 10,603 shares@ US$2.31100.0% of flowOrdinary SharesSEC:0000899243-22-007059:0
2 of 2 declarations
